Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Group Pres., ITT & Pharma. | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 75,045 |
Reported balance
After 2026-03-06 transaction · row 1
1 source rowRow 1 · 2026-03-06 · Tax withholding · Disposed 2,848 · Balance 75,045 F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 2,848 | $17.69 | $50,381.12 |
DisclosureSEC source: 0001628280-26-016412 · wk-form4_1773173275.xml · nonDerivative · entry 1 Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,045 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 00:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,852 | $19.69 | $36,465.88 |
DisclosureSEC source: 0001628280-26-014241 · wk-form4_1772582902.xml · nonDerivative · entry 2 Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,894 F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 57,471 | $0.00 Strike: $20.37 | $0.00 |
DisclosureSEC source: 0001628280-26-014241 · wk-form4_1772582902.xml · derivative · entry 3 Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,471 Underlying: Common Stock, $1 par value · 57,471 shares Expires 2036-02-27 F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 23,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014241 · wk-form4_1772582902.xml · nonDerivative · entry 1 Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,748 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:11 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 918 | $21.73 | $19,948.14 |
DisclosureSEC source: 0001628280-26-007420 · wk-form4_1770855065.xml · nonDerivative · entry 2 Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,006 F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. F3 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:11 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-007420 · wk-form4_1770855065.xml · nonDerivative · entry 1 Soriano Maria Cecilia · CIK 0002098784 · Group Pres., ITT & Pharma. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,924 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.